Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2006, Vol. 107, No. 6, pp. 2384-2391.
Prepublished online as a Blood First Edition Paper on November 10, 2005; DOI 10.1182/blood-2005-07-2883.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-07-2883v1
107/6/2384    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cahuzac, N.
Right arrow Articles by Hueber, A.-O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cahuzac, N.
Right arrow Articles by Hueber, A.-O.
Related Collections
Right arrow Immunobiology
Right arrow Apoptosis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Fas ligand is localized to membrane rafts, where it displays increased cell death–inducing activity

Nathalie Cahuzac, Wiebke Baum, Vladimir Kirkin, Fabien Conchonaud, Laure Wawrezinieck, Didier Marguet, Ottmar Janssen, Martin Zörnig, and Anne-Odile Hueber

From the Equipe labelisée La Ligue; Institute of Signaling, Developmental Biology and Cancer Research, Nice, France CNRS UMR 6543; Chemotherapeutisches Forschungsinstitut, Frankfurt, Germany; Centre d'Immunologie de Marseille Luminy, Université de la Méditerranée, Marseille, France; and Institute of Immunology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.

Fas ligand (FasL), a member of the TNF protein family, potently induces cell death by activating its matching receptor Fas. Fas-mediated killing plays a critical role in naturally and pathologically occurring cell death, including development and homeostasis of the immune system. In addition to its receptor-interacting and cell death–inducing extracellular domain, FasL has a well-conserved intracellular portion with a proline-rich SH3 domain–binding site probably involved in non-apoptotic functions. We report here that, as with the Fas receptor, a fraction of FasL is constitutively localized in rafts. These dynamic membrane microdomains, enriched in sphingolipids and cholesterol, are important for cell signaling and trafficking processes. We show that FasL is partially localized in rafts and that increased amounts of FasL are found in rafts after efficient FasL/Fas receptor interactions. Raft disorganization after cholesterol oxidase treatment and deletions within the intracellular FasL domain diminish raft partitioning and, most important, lead to decreased FasL killing. We conclude that FasL is recruited into lipid rafts for maximum Fas receptor contact and cell death–inducing potency. These findings raise the possibility that certain pathologic conditions may be treated by altering the cell death–inducing capability of FasL with drugs affecting its raft localization.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. Le Lay, Q. Li, N. Proschogo, M. Rodriguez, K. Gunaratnam, S. Cartland, C. Rentero, W. Jessup, T. Mitchell, and K. Gaus
Caveolin-1-dependent and -independent membrane domains
J. Lipid Res., August 1, 2009; 50(8): 1609 - 1620.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Engedal, P. Auberger, and H. K. Blomhoff
Retinoic acid regulates Fas-induced apoptosis in Jurkat T cells: reversal of mitogen-mediated repression of Fas DISC assembly
J. Leukoc. Biol., March 1, 2009; 85(3): 469 - 480.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Ginouves, K. Ilc, N. Macias, J. Pouyssegur, and E. Berra
PHDs overactivation during chronic hypoxia "desensitizes" HIF{alpha} and protects cells from necrosis
PNAS, March 25, 2008; 105(12): 4745 - 4750.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Huang, L. J. Edwards, B. D. Evavold, and C. Zhu
Kinetics of MHC-CD8 Interaction at the T Cell Membrane
J. Immunol., December 1, 2007; 179(11): 7653 - 7662.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sun, S. Lee, S. Karray, M. Levi-Strauss, K. T. Ames, and P. J. Fink
Cutting Edge: Two Distinct Motifs within the Fas Ligand Tail Regulate Fas Ligand-Mediated Costimulation
J. Immunol., November 1, 2007; 179(9): 5639 - 5643.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020